<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01807299</url>
  </required_header>
  <id_info>
    <org_study_id>ADHD_Omega_Exercise</org_study_id>
    <nct_id>NCT01807299</nct_id>
  </id_info>
  <brief_title>The Effect of Physical Training and the Omega 3 Consumption on Attention Deficit Hyperactivity Disorder in Children</brief_title>
  <acronym>AOE</acronym>
  <official_title>The Effect of Physical Training and the Omega 3 Consumption on Attention Deficit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The attention deficit hyperactivity disorder (ADHD) usually occurs in preschool and may cause
      disabilities through whole life.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The attention deficit hyperactivity disorder (ADHD) usually occurs in preschool and may cause
      disabilities through whole life. The treatment of this disease is expensive and difficult.
      Moreover, physical exercise and omegas consumption may improve the cognitive functions and
      behavior, so it could be an interesting strategy to improve this disorder. The aim of the
      present study is to verify the effects of multiple components physical training and the
      consumption of omega 3 on behavior, cognitive functions and the serum levels of BDNF and
      IGF-1 in ADHD children. Thus, 68 ADHD children, between seven and fourteen years old will be
      selected. The volunteers will be randomly divided into four groups: Physical Training Group
      (PTG), Omega Group (OG), Omega and Physical Training Group (OPTG) and Control Group (CG). The
      protocol of the experiment will last three months in which the OPTG will make physical
      training and receive fish oil capsules, and the PTG will make only the physical training and
      receive a placebo of fish oil. The others groups will be oriented not to make any type of
      physical training, but the OG will receive fish oil capsule, and the CG will receive a
      placebo of fish oil. Behavioral and cognitive functions evaluations and blood analysis will
      be made at the beginning and at the end of the protocol.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Conners Scale</measure>
    <time_frame>3 months</time_frame>
    <description>Scores on the Conners scale. Scores above 60 indicate ADHD. Minimum 0 and a maximum of 126.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">68</enrollment>
  <condition>Attention Deficit Hyperactivity Disorder</condition>
  <arm_group>
    <arm_group_label>Physical Training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The training group will make physical exercise for three months (three times a week).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sedentary</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The sedentary group will be oriented not to make any type of physical training for three months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The omega 3 group will receive 2g per day of mineral oil during 90 days treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Omega 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The omega 3 group will receive 2g per day of fish oil during 90 days treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Omega 3</intervention_name>
    <description>Capsules of omega 3, 1000mg / capsules. Administered 3 times a day.</description>
    <arm_group_label>Physical Training</arm_group_label>
    <arm_group_label>Sedentary</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physical Training</intervention_name>
    <arm_group_label>Omega 3</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children with ADHD: male, between seven and fourteen years old, sedentary, studing in
             a regular school.

        Exclusion Criteria:

          -  Taking psychoactive medications, taking omega supplement.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>José Carlos F Galduróz, Md PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidade Federal de São Paulo (UNIFESP)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Departamento de Psicobiologia</name>
      <address>
        <city>São Paulo</city>
        <zip>04024002</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>March 7, 2013</study_first_submitted>
  <study_first_submitted_qc>March 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 8, 2013</study_first_posted>
  <results_first_submitted>February 13, 2019</results_first_submitted>
  <results_first_submitted_qc>February 17, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">February 28, 2020</results_first_posted>
  <last_update_submitted>February 17, 2020</last_update_submitted>
  <last_update_submitted_qc>February 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of São Paulo</investigator_affiliation>
    <investigator_full_name>Jose Carlos Fernandes Galduroz MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Physical Training</keyword>
  <keyword>ADHD-Attention deficit hyperactivity disorder</keyword>
  <keyword>Omega 3</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperkinesis</mesh_term>
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Omega-3</title>
          <description>Take Omega-3 Only</description>
        </group>
        <group group_id="P2">
          <title>Sedentary (Control)</title>
          <description>The sedentary group will be oriented not to make any type of physical training for three months.</description>
        </group>
        <group group_id="P3">
          <title>Placebo + Physical Training</title>
          <description>The omega 3 group will receive 2g per day of mineral oil during 90 days treatment
Physical Training</description>
        </group>
        <group group_id="P4">
          <title>Omega 3 + Physical Training</title>
          <description>The omega 3 group will receive 2g per day of fish oil during 90 days treatment
Physical Training</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="14"/>
                <participants group_id="P3" count="12"/>
                <participants group_id="P4" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="13"/>
                <participants group_id="P3" count="12"/>
                <participants group_id="P4" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Omega-3 Only</title>
          <description>Omega 3: Capsules of omega 3, 1000mg / capsules. Administered 3 times a day.</description>
        </group>
        <group group_id="B2">
          <title>Sedentary (Control)</title>
          <description>The sedentary group will be oriented not to make any type of physical training for three months.
Omega 3: Capsules of omega 3, 1000mg / capsules. Administered 3 times a day.</description>
        </group>
        <group group_id="B3">
          <title>Placebo + Phsycal Training</title>
          <description>The omega 3 group will receive 2g per day of mineral oil during 90 days treatment
Physical Training</description>
        </group>
        <group group_id="B4">
          <title>Omega 3 + Phsycal Training</title>
          <description>The omega 3 group will receive 2g per day of fish oil during 90 days treatment
Physical Training</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="14"/>
            <count group_id="B2" value="14"/>
            <count group_id="B3" value="12"/>
            <count group_id="B4" value="13"/>
            <count group_id="B5" value="53"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10.27" spread="2.20"/>
                    <measurement group_id="B2" value="10.85" spread="2.03"/>
                    <measurement group_id="B3" value="10.36" spread="2.71"/>
                    <measurement group_id="B4" value="10.55" spread="2.94"/>
                    <measurement group_id="B5" value="10.5075" spread="2.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="00"/>
                    <measurement group_id="B2" value="00"/>
                    <measurement group_id="B3" value="00"/>
                    <measurement group_id="B4" value="00"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="13"/>
                    <measurement group_id="B5" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="13"/>
                    <measurement group_id="B5" value="53"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="00"/>
                    <measurement group_id="B2" value="00"/>
                    <measurement group_id="B3" value="00"/>
                    <measurement group_id="B4" value="00"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="00"/>
                    <measurement group_id="B2" value="00"/>
                    <measurement group_id="B3" value="00"/>
                    <measurement group_id="B4" value="00"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Brazil</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="13"/>
                    <measurement group_id="B5" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Conners Scale</title>
        <description>Scores on the Conners scale. Scores above 60 indicate ADHD. Minimum 0 and a maximum of 126.</description>
        <time_frame>3 months</time_frame>
        <population>Conners scale and the child stress scale (ESI)</population>
        <group_list>
          <group group_id="O1">
            <title>Omega-3 Only</title>
            <description>Omega 3: Capsules of omega 3, 1000mg / capsules. Administered 3 times a day.</description>
          </group>
          <group group_id="O2">
            <title>Sedentary (Control)</title>
            <description>The sedentary group will be oriented not to make any type of physical training for three months.</description>
          </group>
          <group group_id="O3">
            <title>Placebo + Phsycal Training</title>
            <description>The omega 3 group will receive 2g per day of mineral oil during 90 days treatment
Physical Training</description>
          </group>
          <group group_id="O4">
            <title>Omega 3 + Phsycal Training</title>
            <description>The omega 3 group will receive 2g per day of fish oil during 90 days treatment
Physical Training</description>
          </group>
        </group_list>
        <measure>
          <title>Conners Scale</title>
          <description>Scores on the Conners scale. Scores above 60 indicate ADHD. Minimum 0 and a maximum of 126.</description>
          <population>Conners scale and the child stress scale (ESI)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.64" spread="12.75"/>
                    <measurement group_id="O2" value="42.31" spread="12.10"/>
                    <measurement group_id="O3" value="40.08" spread="14.47"/>
                    <measurement group_id="O4" value="36.82" spread="7.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.05</p_value>
            <method>Chi-squared, Corrected</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>5</param_value>
            <ci_percent>5</ci_percent>
            <ci_n_sides>1-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Omega-3 Only</title>
          <description>Omega 3: Capsules of omega 3, 1000mg / capsules. Administered 3 times a day.</description>
        </group>
        <group group_id="E2">
          <title>Sedentary (Control)</title>
          <description>The sedentary group will be oriented not to make any type of physical training for three months.</description>
        </group>
        <group group_id="E3">
          <title>Placebo + Phsycal Training</title>
          <description>The omega 3 group will receive 2g per day of mineral oil during 90 days treatment
Physical Training</description>
        </group>
        <group group_id="E4">
          <title>Omega 3 + Phsycal Training</title>
          <description>The omega 3 group will receive 2g per day of fish oil during 90 days treatment
Physical Training</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="00" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="00" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>PhD José Carlos F. Galduróz</name_or_title>
      <organization>Universidade Federal de São Paulo</organization>
      <email>galduroz@unifesp.br</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

